• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • News & Updates
  • Tools & Resources
Home Webinars and One-pagers HepVu Webinar: Harm Reduction Services in the Time of COVID-19

HepVu Webinar: Harm Reduction Services in the Time of COVID-19

June 11, 2020

On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.

To view the recording of the HepVu webinar on “HepVu Webinar: Harm Reduction Services in the Time of COVID-19” please see the video below.

Moderator:
  • Heather Bradley, PhD, Assistant Professor of Epidemiology, Georgia State University, Project Director of HepVu
Speakers:
  • Don Des Jarlais, PhD, Associate Director, Infectious Disease Epidemiology and Theory Core, Center for Drug Use and HIV, and Professor, NYU School of Global Public Health
  • Tyler Bartholomew, Director of Research and Evaluation, The IDEA Exchange
  • Daniel Raymond, Deputy Director of Planning and Policy, Harm Reduction Coalition

To download the presentation, please click here.

Most Read

News & Updates Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025
News & Updates Frank Hood on the Importance of Funding Viral Hepatitis Elimination
Infographics Hepatitis Testing Day 2020
Share Facebook Twitter LinkedIn Email

Keep Reading

March 3, 2021

HepVu Launches County-Level Hepatitis C-Related Mortality Data and Maps Visualizing Hepatitis C’s Impact on Americans at the Local-Level

Read More

March 3, 2021

HepVu Q&A: Dr. Eric Hall on County-Level Hepatitis C-Related Mortality Trends in the U.S.

Read More

March 3, 2021

Hepatitis C-Related Mortality in the U.S. at the County-Level

Read More

February 26, 2021

What’s New in Viral Hepatitis – February 2021

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2021 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us